12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ProCervix: Phase I data

A dose-escalation, Belgian Phase I trial in 47 women with HPV genotype 16 and/or 18 infection showed that ProCervix plus adjuvant was safe up to the highest dose...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >